Vestal Point Capital »

Alto Neuroscience shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Alto Neuroscience (ANRO) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Alto Neuroscience

Tip: Access up to 7 years of quarterly data

All positions including Alto Neuroscience held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alto Neuroscience by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.6M 620k 10.69

More positions owned by Vestal Point Capital

Jazz Pharmaceuticals Shs Usd (JAZZ)
Cytokinetics Com New (CYTK)
Ascendis Pharma A/S Sponsored Adr (ASND)
Ultragenyx Pharmaceutical (RARE)
Globus Medical Cl A (GMED)
Insmed Com Par $.01 (INSM)
BeiGene Sponsored Adr (BGNE)
Soleno Therapeutics (SLNO)
EXACT Sciences Corporation (EXAS)
Arcellx Common Stock (ACLX)
Immatics NV SHS (IMTX)
Janux Therapeutics (JANX)
Astria Therapeutics (ATXS)
Kalvista Pharmaceuticals (KALV)
Savara (SVRA)

View all positions for Vestal Point Capital

Top funds holding Alto Neuroscience

Falcon Edge Capital
RA Capital Management
Point72 Asset Management
72 Investment Holdings
T. Rowe Price Associates
Franklin Resources
Vestal Point Capital
Vanguard Group
BlackRock
Deep Track Capital
Jennison Associates
Philadelphia Financial Management of San Francisco
Artal Group
Board of Trustees of The Leland Stanford Junior University
AWM Investment Company

View all funds holding Alto Neuroscience